Placental Protein-13 and Pregnancy-Associated Plasma Protein-A as First Trimester Screening Markers for Hypertensive Disorders and Small for Gestational Age Outcomes

REFERENCES

• Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357:53–56.
   PubMed Web of Science ®Google Scholar
• Mihu D, Costin N, Mihu CM, Seicean A, Ciortea R. HELLP syndrome—a multisystemic disorder. J Gastrointestin Liver Dis 2007; 16:419–424.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Ramadan MK. Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol 1993; 168:1682–1687.
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007; CD004659.
   Google Scholar
• Hayman R. Hypertension in pregnancy. Curr Obstet Gynaecol 2004; 14:1–10.
   Google Scholar
• Walker JJ. Pre-eclampsia. Lancet 2000; 356:1260–1265.
   PubMed Web of Science ®Google Scholar
• Papageorghiou AT, Yu CK, Nicolaides KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2004; 18:383–396.
   PubMed Web of Science ®Google Scholar
• Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn 2005; 25:949–953.
   PubMed Web of Science ®Google Scholar
• Lawrence JB, Oxvig C, Overgaard MT, The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 1999; 96:3149–3153.
   PubMed Web of Science ®Google Scholar
• Canini S, Prefumo F, Pastorino D, Association between birth weight and first-trimester free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Fertil Steril 2008; 89:174–178.
   PubMed Web of Science ®Google Scholar
• Cowans NJ, Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 2007; 27:264–271.
   PubMed Web of Science ®Google Scholar
• Spencer CA, Allen VM, Flowerdew G, Dooley K, Dodds L. Low levels of maternal serum PAPP-A in early pregnancy and the risk of adverse outcomes. Prenat Diagn 2008; 28:1029–1036.
   PubMed Web of Science ®Google Scholar
• Pilalis A, Souka AP, Antsaklis P, Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11–14 weeks’ gestation. Ultrasound Obstet Gynecol 2007; 29:135–140.
   PubMed Web of Science ®Google Scholar
• Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 2009; 33:23–33.
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Nicolaides KH. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 2008; 28:7–10.
   PubMed Web of Science ®Google Scholar
• Than NG, Pick E, Bellyei S, Functional analyses of placental protein 13/galectin-13. Eur J Biochem 2004; 271:1065–1078.
   PubMedGoogle Scholar
• Burger O, Pick E, Zwickel J, Placental protein 13 (PP-13): Effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 2004; 25:608–622.
   PubMed Web of Science ®Google Scholar
• Sekizawa A, Purwosunu Y, Yoshimura S, PP13 mRNA expression in trophoblasts from preeclamptic placentas. Reprod Sci 2009; 16:408–413.
   PubMed Web of Science ®Google Scholar
• Shimizu H, Sekizawa A, Purwosunu Y, PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia. Prenat Diagn 2009; 29(13):1231–1236.
   PubMed Web of Science ®Google Scholar
• Than NG, Abdul RO, Magenheim R, Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Arch 2008; 453:387–400.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH. Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsia. Prenat Diagn 2009; 29(12):1103–1108.
   PubMed Web of Science ®Google Scholar
• Chafetz I, Kuhnreich I, Sammar M, First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2007; 197:35–37.
   PubMed Web of Science ®Google Scholar
• Gonen R, Shahar R, Grimpel YI, Placental protein 13 as an early marker for pre-eclampsia: A prospective longitudinal study. BJOG 2008; 115:1465–1472.
   PubMed Web of Science ®Google Scholar
• Huppertz B, Sammar M, Chefetz I, Neumaier-Wagner P, Bartz C, Meiri H. Longitudinal determination of serum placental protein 13 during development of preeclampsia. Fetal Diagn Ther 2008; 24:230–236.
   PubMed Web of Science ®Google Scholar
• Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, Harrington K. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk. Prenat Diagn 2009; 29(8):781–789.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Bindra R, Turan OM, A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 2006; 27:13–17.
   PubMed Web of Science ®Google Scholar
• Romero R, Kusanovic JP, Than NG, First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol 2008; 199:122.
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 2007; 29:128–134.
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Chefetz I, Tal J, Kuhnreich I, Meiri H. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia. Prenat Diagn 2007; 27:258–263.
   PubMed Web of Science ®Google Scholar
• Cowans NJ, Spencer K, Meiri H. First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes. Prenat Diagn 2008; 28:121–125.
   PubMed Web of Science ®Google Scholar
• Matwejew E, Cowans NJ, Stamatopoulou A, von Kaisenberg C, Spencer K. Maternal serum ADAM12 as a potential marker for different adverse pregnancy outcomes. Fetal Diagn Ther 2010; 27:32–39.
   Google Scholar
• Cowans NJ, Stamatopoulou A, Matwejew E, von Kaisenberg C, Spencer K. First trimester placental growth factor (PlGF) as a marker for hypertensive disorders and SGA. Prenat Diagn 2010; 30:565–570.
   PubMed Web of Science ®Google Scholar
• Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158:892–898.
   PubMed Web of Science ®Google Scholar
• Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996; 85:843–848.
   PubMed Web of Science ®Google Scholar
• Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999; 13:231–237.
   PubMed Web of Science ®Google Scholar
• Spencer K, Bindra R, Nicolaides KH. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 2003; 23:851–855.
   PubMed Web of Science ®Google Scholar
• Kang JH, Farina A, Park JH, Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: Correlation with the week of onset and the severity. Prenat Diagn 2008; 28:704–709.
   PubMed Web of Science ®Google Scholar
• Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001; 357:209–215.
   PubMed Web of Science ®Google Scholar